SWTX
SpringWorks Therapeutics
SWTX
SWTX
Delisted
SWTX was delisted on the 30th of June, 2025.
147 hedge funds and large institutions have $1.58B invested in SpringWorks Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 48 reducing their positions, and 11 closing their positions.
Holders
147
Holders Change
+5
Holders Change %
+3.52%
% of All Funds
2.34%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
17
Increased
54
Reduced
48
Closed
11
Calls
$256K
Puts
$453K
Net Calls
-$197K
Net Calls Change
+$47K
Top Buyers
| 1 |
1
Pictet Asset Management
Carouge,
Switzerland
|
$24.4M |
| 2 |
MC
2
Maverick Capital
Dallas,
Texas
|
$14.7M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$36M |
| 4 |
4
Morgan Stanley
New York
|
$12.2M |
| 5 |
IC
5
Ikarian Capital
Dallas,
Texas
|
$4.12M |
Top Sellers
| 1 |
1
Bank of America
Charlotte,
North Carolina
|
$17.3M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$59.4M |
| 3 |
ITP
3
Iron Triangle Partners
Cos Cob,
Connecticut
|
$3.47M |
| 4 |
4
Goldman Sachs
New York
|
$13.7M |
| 5 |
O
5
OrbiMed
New York
|
$91.8M |
